Set the COSHH Baseline Before the Vial Reaches the Suite
Commissioning a new tissue-culture suite creates a short but critical window in which procedures, storage and documentation must be fixed before the first research material crosses the threshold. A COSHH-aware inventory is part of that commissioning package, not an administrative afterthought. The inventory should identify what is held, where it is stored, who may use it, how it will be handled and which assessment governs its use. For a UK-sourced research vial, the entry also needs to connect the physical vial to its batch documentation and to the suite’s approved in-vitro workflow.
Begin with the COSHH assessment. The person responsible for the suite should confirm that the substance is being brought in for controlled laboratory or analytical research only and that the intended use fits the supplier’s research-use-only terms. Research materials supplied by UK companies such as Research Sciences are described as strictly for controlled laboratory and analytical research, with labels stating “For Research Use Only – Not for Human Consumption”. That statement is the supplier’s stated position, not legal advice, and it must be repeated in induction and training records: these materials are not for human or veterinary use.
Before receipt, designate a quarantine or receipt-check area. The new suite should have a controlled route for deliveries, a clean bench or tray for inspection, and a storage location that matches the supplier’s handling instructions. Lyophilised research peptides are typically described for storage at –20°C or below, sealed with desiccant and protected from moisture, heat and light; any batch-specific instruction on the label or CoA takes precedence. The inventory record should not be created after the vial is put away. It should be opened at receipt, linked to the COSHH assessment and completed before the vial is released to the bench.
Check the vial against the paperwork at entry. The label reference should combine the SKU and expiry date, and the batch CoA should be opened and checked for the specific item. Published claims, including purity headlines or delivery estimates, should not replace the batch document. If a figure such as ≥99% purity is quoted on the shop’s current page, record it only as published wording and reconfirm it against the batch CoA. Delivery lines are estimates, not guarantees. The inventory is the bridge between the supplier’s published information, the local COSHH assessment and the actual vial.
Building the Inventory Record for a UK-Sourced Vial
A UK-sourced vial should be entered as a controlled item, not as a generic reagent. The record needs enough detail for a second person to locate the vial, understand its status and trace it back to the batch documentation without guessing. Use a unique inventory identifier and keep it stable through receipt, use and disposal. The product name and SKU should match the label exactly. The batch reference or Internal Test Reference (ITR) should be recorded where provided, with a clear note that an ITR links to associated sample testing reports and does not confirm that separate deliveries came from the same production lot or received separate independent testing.
The CoA reference belongs in the inventory, together with the expiry date, storage condition, quantity received, current quantity, location and status. Status options include quarantine, released for in-vitro use, in use and awaiting disposal. Record the COSHH assessment number, approved SOP, responsible person, waste route and date received. Where a batch is sourced through Peptide uk, the same fields apply: the inventory must stand on the batch label and CoA, not on the product name alone. Vial cap colour may vary and is not an indicator of identity, analytical quality or manufacturing origin.
If the suite permits reconstitution for an in-vitro assay, the inventory should show the laboratory workflow, not a clinical one. Record the diluent, the planned concentration for the assay, the date of preparation, the preparer and the short-term storage location. Reconstituted material is less stable and is typically described for 2–8°C storage for short-term laboratory use; avoid repeated freeze–thaw cycles. The free reconstitution calculator offered by the supplier is a laboratory planning aid only and must not be used for human or veterinary dosing. These materials are not for human or veterinary use, and any reconstitution entry should make that clear.
Use the vial label reference when querying documentation. If the label reads, for example, a SKU followed by an expiry date, quote that reference when contacting the shop about the CoA. If the supplier lists “CoAs Janoshik Analytical Reports” on its current page, treat that as published wording and open the CoA that accompanies the specific batch. The record should include the date the CoA was checked and the initials of the checker. That simple audit point turns a stock line into a COSHH-aware inventory entry.
Commissioning Controls: Storage, Access and Audit Trails
Once the vial is logged, the new suite needs to prove that the inventory is live. Storage must match the record. A designated freezer, fridge or desiccated container should be labelled with the inventory identifier or a controlled location code, and access should be restricted to trained staff. Temperature monitoring, if part of the suite’s commissioning plan, should be documented through the institution’s own procedures. The inventory should show when a vial moves between storage and bench, who took it and how much was removed. Only the amount required for the experiment should be taken, and the remainder returned promptly to the correct condition.
Waste and spill control belong in the same record. Even where the hazard profile is limited, the COSHH assessment should define the waste stream, spill response and decontamination route. Training records should reference the inventory entry, CoA check and RUO label. Materials are not for human or veterinary use, and that message should appear in induction slides, bench cards and the inventory’s status screen. A new tissue-culture suite is also a new environment for contamination control; vial, paperwork and packaging movement should follow the suite’s material-transfer rules, keeping outer packaging out of clean zones where local procedures require it.
Audit the inventory at commissioning and again after the first month of use. Reconcile quantities received, used and disposed. Check that every CoA reference resolves to a batch document and that no vial has been released without a COSHH assessment. Review storage temperatures against the record, confirm expiry dates are visible and remove quarantined items from general access. If the supplier’s published terms change, update the local record and note the date of recheck. Headline figures such as order counts or delivery windows are marketing or fulfilment statements published at the time of writing; reconfirm them on the live site and do not treat them as batch specifications.
The strongest commissioning test is a traceability test. Ask a colleague who did not receive the vial to find the inventory entry, locate the physical item, open the correct batch CoA and state the approved in-vitro use and waste route. If any step depends on memory or a loose email, the record is incomplete. The inventory entry is finished only when the vial, the CoA and the COSHH assessment point to the same batch and the same approved use.
